Amicogen Inc. (092040) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Amicogen Inc. (092040:KRX), powered by AI.

Current Price
₩1,294
P/E Ratio
-3.1
Market Cap
91.4B
Sector
Healthcare
What is the Amicogen Inc. stock price forecast?

Amicogen Inc. is currently trading at ₩1,294. View real-time AI analysis on Alpha Lenz.

What is Amicogen Inc. insider trading activity?

View the latest insider trading data for Amicogen Inc. on Alpha Lenz.

What is Amicogen Inc.'s P/E ratio?

Amicogen Inc.'s P/E ratio is -3.1.

Amicogen Inc.

KRX · 092040
₩1,294-10(-0.77%)Market closedKRX regular session 09:00–15:30 KST
Ask about Amicogen Inc.'s future dividend policy...
Alpha Chat Insight

Amicogen Inc. trades at a P/E of -3.1 (undervalued) with modest ROE of -27.6%.

Ask for details

Company Overview

Amicogen Inc. operates within the biotechnology sector, focusing on the development and production of special enzymes pivotal for pharmaceutical, food, and environmental applications. The company is renowned for its innovative approaches in enzyme engineering and bioprocessing, which are crucial for enhancing the efficiency and sustainability of various industrial processes. By leveraging its proprietary technology platform, Amicogen Inc. produces enzymes that act as catalysts in diverse chemical reactions, significantly impacting the pharmaceutical industry by improving drug synthesis and reducing production costs. Additionally, these enzymes find applications in producing healthier food products and eco-friendly solutions for waste management. In the financial market, Amicogen Inc. represents a significant player among biotech firms, contributing to advancements in green technology practices while supporting the healthcare industry's evolving needs. This aligns with global economic trends towards sustainability and innovation, enhancing its role in the market.

CEO표쩌
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees225

Company Statistics

FY 2025

Profile

₩91,428,070,778Market Cap
₩41,981,406,100Revenue
70.66MShares Out
225Employees

Margins

13.13%Gross
-23.53%EBITDA
-36.00%Operating
-71.16%Pre-Tax
-72.33%Net

Valuation

-3.05P/E
0.97P/B
2.18EV/Sales
-18.29EV/EBITDA
-3.24P/FCF

Growth (CAGR)

-33.74%Rev 3Yr
-18.37%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-11.54%ROA
-27.60%ROE
-8.41%ROIC

Financial Health

₩6,239,028,420Cash & Cash Equivalents
₩129,764,511,000Net Debt
141.88%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Amicogen Inc. (ticker: 092040) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 225 employees. Market cap is $91.4B.

The current price is ₩1,294 with a P/E ratio of -3.05x and P/B of 0.97x.

ROE is -27.60% and operating margin is -36.00%. Annual revenue is $42.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Amicogen Inc. (092040) Stock Forecast 2026 ₩1,294 — Price, Financials & Analyst Targets | Alpha Lenz